Royal College of Surgeons Ireland-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Royal College of Surgeons Ireland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011859
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Royal College of Surgeons Ireland (RCSI) is a not-for-profit organization that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The organization offers undergraduate courses in nursing, postgraduate research, postgraduate taught, leadership courses, and surgical affairs. It include schools, faculties and departments that offers services in the areas of medicine, pharmacy, physiotherapy, academic and regulatory affairs, sports and exercise medicine, dentistry, radiology, and others. The organization’s research areas include bioengineering, cancer, cardiovascular, nursing, infection, immunity and inflammation, medicine, neuroscience, gynecology and obstetrics, and others. RCSI is headquartered in Dublin, Ireland.

Royal College of Surgeons Ireland – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Inflection Biosciences Enters into Agreement with Royal College of Surgeons 10
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 11
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 12
Royal College of Surgeons Ireland – Key Employees 13
Royal College of Surgeons Ireland – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Feb 20, 2017: RCSI research into bowel cancer drugs to have impact on tailored patient treatments 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Key Facts 2
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Royal College of Surgeons Ireland, Deals By Therapy Area, 2011 to YTD 2017 8
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Inflection Biosciences Enters into Agreement with Royal College of Surgeons 10
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 11
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 12
Royal College of Surgeons Ireland, Key Employees 13

★海外企業調査レポート[Royal College of Surgeons Ireland-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RP Management LLC-製薬・医療分野:企業M&A・提携分析
    Summary RP Management LLC (RP Management) is a life sciences financing company which offers biopharmaceutical products. Its products portfolio includes rituxan, atripla, thalomid, myozyme, lexiscan, januvia, onglyza, lyrica, prezista, letairis, rotateq, cubicin, savella, neupogen, and others. The co …
  • Credit Agricole Normandie-Seine (CCN):企業概要、財務及び戦略的SWOT分析
    Summary Credit Agricole Normandie-Seine (Credit Agricole) is a financial service provider. The company provides banking services to its customers. It offers products such as credit account, savings account, debit card, payment services and insurance. Credit Agricole offers loan products which includ …
  • Biomm S.A. (BIOM3)(製薬・医療分野):企業M&A動向
    Summary Biomm S.A. (Biomm) is a biotechnology company. The company develops technology for the production of human insulin and other recombinant proteins. Its technology is used in the production of therapeutic proteins, such as calcitonin, interferons and growth hormones. The company offers process …
  • Nippon Techno Lab Inc. (3849):企業概要、財務及び戦略的SWOT分析
    Summary NIPPON TECHNO LAB INC. (NIPPON TECHNO) is an information technology company. The company develops and provides software solutions to its clients. It offers printer controllers, storage solutions, information security products, video security software, software package, entrusted development, …
  • Offshore Oil Engineering Co., Ltd. (600583):企業財務及び戦略的SWOT分析
    Summary Offshore Oil Engineering Co., Ltd. (COOEC), a subsidiary of China National Offshore Oil Corporation is an offshore engineering company that provides offshore engineering construction services. The company offers services such as engineering, procurement, construction, installation, maintenan …
  • Ramky Infrastructure Limited (RAMKY):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Ramky Infrastructure Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stric …
  • Biome Technologies plc (BIOM):企業概要、財務及び戦略的SWOT分析
    Summary Biome Technologies plc (Biome) is a bio-plastic manufacturer. The company conducts business through the divisions such as bioplastics and stanelco RF Technologies. It supplies biodegradable natural polymers. Biome’s bioplastics division supplies plastics made from renewable resources. Biome’ …
  • MDF Instruments Direct, Inc.:企業の戦略的SWOT分析
    MDF Instruments Direct, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Stellar Resources Limited:企業の戦略・SWOT・財務分析
    SummaryStellar Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Exploration and Production KazMunaiGas (KMG):企業のM&A・提携動向(石油・ガス分野)
    Summary Exploration and Production KazMunaiGas (KMG EP), a subsidiary of National Company KazMunaiGas, is an upstream oil and gas company. The company carries out the exploration, development, production, processing and export of hydrocarbons and acquisition of oil and gas assets in Kazakhstan. It h …
  • Micrel, Incorporated (MCRL):企業の財務及び戦略的SWOT分析
    Summary Micrel, Incorporated (Micrel) is an electronic component manufacturer that develops and offers IC solutions for automotive and home automation applications. The company’s products include power management ICs, linear ICs, bus device ICs, system management ICs, precision edge ICs, fiber optic …
  • Medical Developments International Limited (MVP):企業概要、財務及び戦略的SWOT分析
    Summary Medical Developments International Limited (MDI) is a pharmaceutical company. The company develops, manufactures and markets pain relief and respiratory medicine. Its products include penthrox, asthma and COPD, MyMDI, rescue and resuscitation, veterinary and defibrillators. The company marke …
  • NCL Industries Ltd. (NCLIND):企業の財務及び戦略的SWOT分析
    Summary NCL Industries Ltd. (NCL) is a diversified energy company that operates through five business divisions such as Cement, Ready Mixed Concrete, Cement Bonded Particle Board, Prefab Houses and Hydropower. The company’s cement division serves construction industry of Andhra Pradesh. Its RMC divi …
  • Teledyne Scientific and Imaging, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Teledyne Scientific and Imaging …
  • Park Place Energy Corp. (PKPL):企業財務及び戦略的SWOT分析
    Summary Park Place Energy Corp. (Park Place), formerly ST Online Corp., is an energy company that offers development and exploration of oil and natural gas. The company offers service such as drilling and other services. Its project includes Vranino Gas project situated in close proximity to a major …
  • Almirall S.A.:企業の戦略・SWOT・財務分析
    SummaryAlmirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • UCB S.A.:企業のM&A・提携・投資分析
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • SOCO International plc (SIA):企業のM&A・提携動向(石油・ガス分野)
    Summary SOCO International plc (SOCO) is an oil and gas company that offers explores, produces, discovers and produces oil and gas reserves. The company provides appraisal and field development and production. It offers training and skills and support local communities. SOCO produces and supplies na …
  • Kyung-In Synthetic Corporation (012610):企業の財務及び戦略的SWOT分析
    Summary Kyung-In Synthetic Corporation (Kyung-In) is a chemical industry. The company researches and develops reactive, disperse, fluorescent, and acidic chemical dyes. It offers products such as disperse dye, direct dye, acid dye, leather dye, fluorescent brightener, solvent, electronic material an …
  • Bain & Company, Inc.:戦略・SWOT・企業財務分析
    Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆